Stomach Cancer Research in NZ: Hope for targeted drug intervention

Parry Guilford, BSc, MSc, PhD

There’s exciting news of promising stomach cancer research going on in New Zealand! Dr. Parry Guilford, Associate Professor at the Cancer Genetics Laboratory, University of Otago, Dunedin, NZ explains how their work, which targets the CDH1 gene, has broader implications in the treatment of stomach cancer.

No Stomach for Cancer, Inc. highlights promising research for new drugs lethal to only cancer cells and single-cell cancer detection

3 Responses to Stomach Cancer Research in NZ: Hope for targeted drug intervention

  1. Julie says:

    As a CDH1 mutation carrier, and someone who had a prophylactic total stomach removal, as well as has lost too many people to stomach cancer, I am so thankful for Dr. Perry Guilford’s past research and this latest quest. He has done so much for all of us who carry this deadly genetic mutation.

  2. Barb Parranto says:

    I will be following this research for stomach cancer closely as I am waiting for the results of my genetic testing for the CDH1 gene.

    • Beth Lambert says:

      Hi Barb,

      Best of luck. Waiting for the results is challenging. I remember waiting for our results and it was extremely difficult. I remember feeling helpless.Please continue to reach out to us so we can help you as you learn more about the genetic mutation. Hoping for good results. Please keep us posted.


Leave a Reply

Return to Top
Contribute Now

Be Our Guest

Share your experience. Learn how you can become a guest contributor to the NSFC Blog.